About MyRx
MyRx is a Healthcare company based in Hyderabad (India) founded in 2014 by Surjit Das, Prafull Pandey, and Sourav Das. Digital practice management software for healthcare professionals is provided. MyRx has raised $78.37 thousand across 3 funding rounds from investors including SteerX. Its chief executive, as recorded, is Sourav Das. Its Indian entity Platinoid Technologies Private Limited reported revenue of ₹84 Lakh. MyRx offers products and services including MyRx Prescription Writer. Its focus areas include HealthTech, Healthcare IT, Provider and Aids for Doctors. Its competitors include WonDRx, SimboAlpha and Pheal; 3 of its 3 listed competitors have raised funding.
Company details
MyRx was founded in 2014 in Hyderabad, India, within the healthcare technology sector. Operations focus on delivering software that supports clinic workflows, including appointment scheduling, patient health record maintenance, and collaboration tools. Prescription templates are customized to align with specific practice requirements. The platform aids daily administrative tasks for medical professionals across various clinic settings.
- Headquarters Hyderabad, India
- Founders Surjit Das, Prafull Pandey, Sourav Das
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website myrx.in
- Social LinkedIn Facebook Instagram
- Legal Name Platinoid Technologies Private Limited
- Date of Incorporation 24 Dec, 2019
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹84 Lakh
FY 2025 · +109% YoY
- Net Profit₹5 Lakh
FY 2025 · 6% margin
- EBITDA₹7.3 Lakh
FY 2025 · 9% margin
- Total Equity Funding$78.37K (USD)
in 3 rounds
- Investors
Associated legal entities of MyRx
MyRx operates through Platinoid Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Platinoid Technologies Private Limited CIN U72900TG2019PTC137889 | Active | 24 Dec 2019 | Hyderabad, Telangana | ₹0.8 Cr | 4 | View details |
Products & Services of MyRx
MyRx offers a comprehensive portfolio of products and services, including MyRx Prescription Writer.
Application for creating and sharing digital prescriptions efficiently.
Funding Insights of MyRx
MyRx has successfully raised a total of $78.37K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $78,372
- Total Rounds 3
- First Round $78,372
(Mar 2025)
- Investors Count 1
All 3 funding rounds of MyRx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | Seed | – | SteerX | – | |
| Sep 2025 | Angel Round | – | – | – | |
| Mar 2025 | $78,372 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in MyRx
MyRx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SteerX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| steerx.vc |
Investor details for MyRx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Platinoid Technologies Private Limited (MyRx)
Platinoid Technologies Private Limited is the primary company behind MyRx. The board of Platinoid Technologies Private Limited currently have 4 directors; the longest-serving is Surjit Das, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Surjit Das DIN 08465074 | Director | 24 Dec 2019 | 6 yrs 10 mo | Platinoid Technologies Private Limited |
| Sourav Das DIN 07075362 | Director | 24 Dec 2019 | 6 yrs 10 mo | Platinoid Technologies Private Limited |
| Nilamadhaba Rath DIN 07874058 | Director | 24 Dec 2019 | 6 yrs 10 mo | Platinoid Technologies Private Limited |
| Sujit Kumar Agrawal DIN 10833058 | Additional Director | 11 Nov 2024 | 1 yr 11 mo | Platinoid Technologies Private Limited |
People of MyRx
3 people are tracked at MyRx (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & COO | Leadership | |
Prafull Pandey | Co-Founder & Director Of Technology | Leadership |
| Co-Founder & CEO | Leadership |
Complete people profiles for MyRx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MyRx
Figures of Platinoid Technologies Private Limited, the primary company behind MyRx, for FY 2025. Revenue was ₹84 Lakh (+109% year on year). Net profit was ₹5 Lakh (6% margin). EBITDA was ₹7.3 Lakh (9% margin). Revenue has grown at a compounded annual rate of +33% over three years and +284% over five years.
- ₹84 LakhRevenue · FY 2025 · +109% YoY
- ₹5 LakhNet profit · 6% margin
- ₹7.3 LakhEBITDA · 9% margin
- ₹1.49 CrPaid-up capital
- +33%Revenue CAGR, 3 years
- +284%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Platinoid Technologies Private Limited are on its company page.
Detailed financial statements for MyRx
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of MyRx
3 dated milestones of MyRx across 12 years, from founding to its latest funding, stage changes and deals.
- Founded MyRx is founded.
- Funding First funding round of $78K.
- Funding Latest funding round, Seed,.
Competitors of MyRx
MyRx has 3 listed competitors in our database, 3 of them funded. They include WonDRx, SimboAlpha and Pheal.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wondrx.com | 2017 | Mumbai, India | $3.24M | 12 | EHR facilitator solutions are provided for healthcare professionals' record management. | |
| simboalpha.com | 2013 | Bengaluru, India | $880,691 | AI-based EMR management is offered to healthcare professionals. | ||
| pheal.in | 2021 | Mumbai, India | $284,522 | A digitized prescription tool is provided for physical therapists. |
Detailed competitors of MyRx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MyRx
The website of MyRx (myrx.in) receives about 5.5K visits a month.
- Monthly visits5.5K
▼ 61.6% vs previous month
Websites whose visitors overlap most with MyRx. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| continuouscare.io | 100% | 10.4K | #2,031,668 | View details | |
prescriptionmaker.com | prescriptionmaker.com | 91% | – | ||
steppie.net | steppie.net | 85% | #5,787,040 | – | |
| digitalprescriptionmaker.com | 76% | #647,675 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Myrx
Complete news archive for MyRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MyRx
MyRx was founded in 2014 and raised its 1st funding round 11 years after it was founded.
MyRx is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Sourav Das is the CEO of MyRx, as recorded in our data. They have also founded this company.
MyRx is a funded company, having raised a total of $78.37K across 3 funding rounds to date. The company's 1st funding round was a Seed of $78.37K, raised on Mar 2025.
The primary company behind MyRx, Platinoid Technologies Private Limited, reported revenue of ₹84 Lakh for FY 2025, up 109% year on year.
MyRx was founded in 2014 in Hyderabad, India, within the healthcare technology sector. Operations focus on delivering software that supports clinic workflows, including appointment scheduling, patient health record maintenance, and collaboration tools. Prescription templates are customized to align with specific practice requirements. The platform aids daily administrative tasks for medical professionals across various clinic settings.
MyRx's top competitors include SimboAlpha, WonDRx and Pheal.
MyRx offers MyRx Prescription Writer.
MyRx has 1 investor. Key investors include SteerX.
MyRx operates through Platinoid Technologies Private Limited.
The legal entities of MyRx currently have 4 directors, including Surjit Das, Sourav Das, Sujit Kumar Agrawal and others.